Señales en vivo de CODX | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 jul 2024 @ 12:11):
Our systems believe the stock currently is overvalued by -0.13% compare to its pairs and should correct downwards.

Stats
Volumen de hoy	63 360
Volumen promedio	126 891
Capitalización de mercado	38.46M
EPS	$-0.310 ( Q1 \| 2024-05-09 )
Próxima fecha de ganancias	( $-0.340 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.940 (Sector) 42.63 (Industry) 0
ATR14	$0.00600 (0.49%)

AEMD -5.53%

AFIB -12.68%

AHCO -1.50%

AHPI 0.00%

ALGN -0.92%

ANIK 2.40%

APEN 0.00%

APYX 1.48%

ARAY -3.02%

ATEC -5.07%

AXDX -2.65%

AXGN 6.09%

AXNX 0.05%

AZYO 2.05%

BBLG -1.62%

BIOL 20.00%

BJDX -0.89%

BMRA 4.55%

BRKR -2.99%

BSGM -2.88%

BWAY -2.87%

CERS -0.28%

CFMS 0.44%

CLPT 0.74%

CODX -1.62%

CSII 0.15%

CTKB 0.18%

CTSO 4.57%

CUTR 0.00%

CVRX -6.09%

DCTH -1.31%

DXCM -1.21%

DYNT -0.04%

EAR -4.10%

ECOR -2.33%

EDAP -2.94%

ESTA -5.06%

FONR 0.75%

HJLI -1.98%

HSDT -0.06%

HSKA 0.00%

HYPR 3.65%

IART -0.76%

ICAD -0.38%

ICCM -2.58%

IINN -13.04%

INGN -2.09%

INMD -0.58%

IRIX -0.55%

IRMD -1.38%

IRTC -1.54%

ISO 0.00%

ITMR 0.00%

KIDS -2.85%

LHDX 0.00%

LIVN 0.07%

LNSR -3.78%

LUCD -2.44%

LUNG -2.52%

MASS -6.21%

MDGS 10.28%

MOTS 16.31%

MOVE 5.13%

MSON 0.00%

NAOV 3.54%

NARI 2.49%

NMRD 33.33%

NNOX -3.00%

NPCE 0.53%

NTUS 0.00%

NURO 0.81%

NUVA -2.24%

NUWE -12.61%

NVCN 0.00%

NVNO -1.52%

OBLN -5.86%

OFIX -2.19%

OM -4.42%

PACB -7.69%

PAVM 1.20%

PETV -23.08%

PODD -1.75%

PRCT 0.88%

PROF 1.15%

QIPT -2.17%

QTRX -4.31%

RCEL -1.52%

RPID 2.80%

RSLS 2.40%

RWLK 6.07%

RXST -1.89%

SGHT -3.00%

SIBN -1.01%

SIEN -18.69%

SILK -0.06%

SINT -3.21%

SOLY 0.00%

SRDX -0.15%

SRGA 0.00%

SRTS -4.88%

SWAV 0.00%

TBIO 12.06%

TCMD -3.18%

TELA -1.17%

THMO 9.52%

TIVC 0.52%

TLIS -1.99%

TMCI -1.65%

TMDI 0.00%

TMDX 0.90%

TNDM -2.93%

TNON 14.02%

UFPT 6.23%

VERO -5.42%

VIVE 0.00%

VMD -2.29%

VRAY 0.00%

VREX -2.44%

VVOS 3.15%

XAIR 4.63%

XENT 0.00%

ZIMV -0.33%

Insider Trading

Date	Person	Action	Amount	type
2024-05-23	Brown Brian Lee	Sell	113 334	Restricted Stock Unit
2024-05-23	Brown Brian Lee	Buy	113 334	Common Stock
2024-05-23	Brown Brian Lee	Sell	35 865	Common Stock
2024-05-23	Egan Dwight H	Sell	138 333	Restricted Stock Unit
2024-05-23	Egan Dwight H	Buy	138 333	Common Stock

INSIDER POWER
38.28
Last 97 transactions
Buy: 4 378 000 \| Sell: 1 648 663

Correlación (AI algo v.1.1b): Overvalued: -0.13% $1.231 paired level. (El Algoritmo Rastrea Los Cambios De Las Acciones Más Correlacionadas En Tiempo Real Y Proporciona Una Actualización Instantánea)

Volumen Correlación

Largo: -0.04 (neutral)

Corto: 0.47 (neutral)

Signal:(56.653) Neutral

Co-Diagnostics Inc Correlación

10 Correlaciones Más Positivas
OZEM	1
RVYL	0.901
ABLV	0.9
CARM	0.899
HOLO	0.897
OCEA	0.892
ATXS	0.891
LUXH	0.89
FRGT	0.89
ADNWW	0.89

10 Correlaciones Más Negativas
CNRLX	-0.898
ISRL	-0.886
ATMV	-0.884
JAJWX	-0.88
ANSC	-0.877
NNAVW	-0.876
AGNCP	-0.875
RENE	-0.872
DTI	-0.868
FORL	-0.862

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Co-Diagnostics Inc Correlación - Moneda/Commodity

-0.80
( moderate negative )

-0.79
( moderate negative )

0.00
( neutral )

-0.57
( weak negative )

0.57
( weak )

0.33
( neutral )

Co-Diagnostics Inc Finanzas

Annual	2023
Ingresos:	$991 473
Beneficio Bruto:	$-4.42M (-446.20 %)
EPS:	$-1.200

FY	2023
Ingresos:	$991 473
Beneficio Bruto:	$-4.42M (-446.20 %)
EPS:	$-1.200

FY	2022
Ingresos:	$34.22M
Beneficio Bruto:	$28.74M (83.98 %)
EPS:	$-0.450

FY	2021
Ingresos:	$97.89M
Beneficio Bruto:	$86.31M (88.18 %)
EPS:	$1.270

Financial Reports:

No articles found.

Co-Diagnostics Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Co-Diagnostics Inc

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.